AUPH logo

AUPH
Aurinia Pharmaceuticals Inc

46,461
Mkt Cap
$2.09B
Volume
955,981.00
52W High
$16.48
52W Low
$6.55
PE Ratio
27.96
AUPH Fundamentals
Price
$15.69
Prev Close
$15.85
Open
$15.95
50D MA
$13.94
Beta
0.96
Avg. Volume
2.23M
EPS (Annual)
$0.0393
P/B
5.66
Rev/Employee
$1.81M
Loading...
Loading...
News
all
press releases
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH
Marex Group plc purchased a new position in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH
Armistice Capital LLC trimmed its stake in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 67.4% in the second quarter, according to the company in its most recent...
MarketBeat·4d ago
News Placeholder
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?
Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Zacks·6d ago
News Placeholder
Arrowstreet Capital Limited Partnership Has $9.12 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH
Arrowstreet Capital Limited Partnership lowered its holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 34.4% in the second quarter, according to the company in its most...
MarketBeat·6d ago
News Placeholder
State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH
State Board of Administration of Florida Retirement System lifted its holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 240.9% during the 2nd quarter, according to its...
MarketBeat·9d ago
News Placeholder
What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?
Does Aurinia Pharmaceuticals (AUPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·10d ago
News Placeholder
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 5.2% - Time to Sell?
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 5.2% - What's Next...
MarketBeat·11d ago
News Placeholder
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) has received a consensus recommendation of "Hold" from the five ratings firms that are covering the stock, MarketBeat Ratings...
MarketBeat·14d ago
News Placeholder
Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH
Virtus Investment Advisers LLC lifted its holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 45.7% during the 2nd quarter, according to its most recent filing with the...
MarketBeat·16d ago
News Placeholder
Advantage Alpha Capital Partners LP Takes $204,000 Position in Aurinia Pharmaceuticals Inc $AUPH
Advantage Alpha Capital Partners LP purchased a new position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) in the second quarter, according to its most recent filing with the...
MarketBeat·17d ago
<
1
2
...
>

Latest AUPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.